Predictors for the Efficacy of 4-Week Dupilumab Treatment in Atopic Dermatitis Patients
Ling Yu,1 Cheng Lian,2 Linfeng Li,3 JianGuo Li,1 Shoumin Zhang1 1Department of Dermatology, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Henan University People’s Hospital, Zhengzhou, Henan, People’s Republic of China; 2Department of Hematology, Henan Provincial People...
Saved in:
| Main Authors: | Yu L, Lian C, Li L, Li J, Zhang S |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Journal of Asthma and Allergy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/predictors-for-the-efficacy-of-4-week-dupilumab-treatment-in-atopic-de-peer-reviewed-fulltext-article-JAA |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023-03-01) -
Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01) -
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01) -
New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01) -
Dupilumab for the treatment of atopic dermatitis and alopecia areata with incidental improvement of trachyonychia
by: Dana H. Chung, BA, et al.
Published: (2025-09-01)